These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31352449)

  • 1. Diagnostic Value of the EZH2 Immunomarker in Malignant Effusion Cytology.
    Ang PP; Tan GC; Karim N; Wong YP
    Acta Cytol; 2020; 64(3):248-255. PubMed ID: 31352449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EZH2, a unique marker of malignancy in effusion cytology.
    Jiang H; Gupta R; Somma J
    Diagn Cytopathol; 2014 Feb; 42(2):111-6. PubMed ID: 23636867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY; Li GD; Liu WP; Xie B; Jiang YH
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
    Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
    Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of EZH2 and MOC-31 expression in the differential diagnosis of benign and malignant effusions.
    Sadullahoglu C; Nart D; Veral A
    Diagn Cytopathol; 2017 Feb; 45(2):118-124. PubMed ID: 28024110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers.
    Davidson B; Risberg B; Kristensen G; Kvalheim G; Emilsen E; Bjåmer A; Berner A
    Virchows Arch; 1999 Jul; 435(1):43-9. PubMed ID: 10431845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential diagnostic value of B72.3, Ber-EP4 and calretinin in serous effusions].
    Li XJ; Pan QJ; Shen GH; Liu XY; Sun YT
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):438-41. PubMed ID: 16188134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of Claudin-4 and EZH2 Immunohistochemistry in Effusion Cytology.
    Elhosainy A; Hafez MMA; Yassin EH; Adam M; Elnaggar MS; Aboulhagag NA
    Asian Pac J Cancer Prev; 2022 Aug; 23(8):2779-2785. PubMed ID: 36037134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical utility of claudin-4 versus those of Ber-EP4 and MOC-31 in effusion cytology.
    Oda T; Ogata S; Kawaguchi S; Minabe S; Dokyu M; Takahashi H; Kumazawa F; Shimazaki H; Takano M; Hase K; Ozeki Y; Kanoh S; Nakanishi K
    Diagn Cytopathol; 2016 Jun; 44(6):499-504. PubMed ID: 27015745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells.
    Davidson B; Nielsen S; Christensen J; Asschenfeldt P; Berner A; Risberg B; Johansen P
    Am J Surg Pathol; 2001 Nov; 25(11):1405-12. PubMed ID: 11684957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
    Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
    Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic utility of D2-40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology.
    Hyun TS; Barnes M; Tabatabai ZL
    Acta Cytol; 2012; 56(5):527-32. PubMed ID: 23075894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
    Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA
    Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ber-EP4 staining in effusion cytology: A potential source of false positives.
    Díaz Del Arco C; Saiz-Pardo Sanz M; Ortega Medina L; Fernández Aceñero MJ
    Rev Esp Patol; 2021; 54(2):114-122. PubMed ID: 33726887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of MOC-31 monoclonal antibody in differentiating metastatic adenocarcinoma cells and reactive mesothelial cells in effusion cytology.
    Patil B; Shivkumar V; Gangane N
    Indian J Pathol Microbiol; 2018; 61(1):90-93. PubMed ID: 29567891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Accuracy of a Limited Immuno-panel of Calretinin and Ber-EP4 for Diagnosis of Malignant Effusions.
    Khurram N; Anis T; Yusuf NW
    J Coll Physicians Surg Pak; 2019 Jan; 29(1):33-36. PubMed ID: 30630566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
    Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
    Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions. Comparison with carcinoembryonic antigen, B72.3 and Leu-M1.
    Bailey ME; Brown RW; Mody DR; Cagle P; Ramzy I
    Acta Cytol; 1996; 40(6):1212-6. PubMed ID: 8960030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P16 as a marker of carcinoma in effusions and peritoneal washing.
    Carneiro FP; Amorim RF; de Vasconcelos Carneiro M; de Castro TMML; de Souza Vianna LM; Takano GHS; Daros AC; Peres I; Kuckelhaus SAS; Motoyama AB
    BMC Cancer; 2020 Mar; 20(1):225. PubMed ID: 32178642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology.
    Ko EC; Jhala NC; Shultz JJ; Chhieng DC
    Am J Clin Pathol; 2001 Nov; 116(5):709-15. PubMed ID: 11710688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.